Cargando…
Towards discovery of novel scaffold with potent antiangiogenic activity; design, synthesis of pyridazine based compounds, impact of hinge interaction, and accessibility of their bioactive conformation on VEGFR-2 activities
Pyridazine scaffolds are considered privileged structures pertaining to its novelty, chemical stability, and synthetic feasibility. In our quest towards the development of novel scaffolds for effective vascular endothelial growth 2 (VEGFR-2) inhibition with antiangiogenic activity, four novel series...
Autores principales: | Jaballah, Maiy Y., Serya, Rabah A. T., Saad, Nasser, Khojah, Sohair M., Ahmed, Marawan, Barakat, Khaled, Abouzid, Khaled A. M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6746272/ https://www.ncbi.nlm.nih.gov/pubmed/31852269 http://dx.doi.org/10.1080/14756366.2019.1651723 |
Ejemplares similares
-
Design and synthesis of phthalazine-based compounds as potent anticancer agents with potential antiangiogenic activity via VEGFR-2 inhibition
por: Elmeligie, Salwa, et al.
Publicado: (2019) -
Discovery of Potent VEGFR-2 Inhibitors based on Furopyrimidine and Thienopyrimidne Scaffolds as Cancer Targeting Agents
por: Aziz, Marwa A., et al.
Publicado: (2016) -
Molecular design, synthesis and in vitro biological evaluation of thienopyrimidine–hydroxamic acids as chimeric kinase HDAC inhibitors: a challenging approach to combat cancer
por: Abdel-Atty, Mona M., et al.
Publicado: (2021) -
YLT192, a Novel, Orally Active Bioavailable Inhibitor of VEGFR2 Signaling with Potent Antiangiogenic Activity and Antitumor Efficacy in Preclinical Models
por: Xia, Yong, et al.
Publicado: (2014) -
Design and Synthesis of New Quinoxaline Derivatives as Anticancer Agents and Apoptotic Inducers
por: El Newahie, Aliya M. S., et al.
Publicado: (2019)